PT. Dataindo Inti Swakarsa

          PT. Dataindo Inti Swakarsa
Membership | FAQ | About | Contact | Home 

Indonesia Companies - Indonesia Industry Reports - Indonesia Trade Reports - Indonesia Bilateral Reports
SEARCH  
MEMBER LOGIN    

Related Reports

Related Indonesia Industry Reports
F61343 - Medical and Laboratory Equipment Wholesaling
Company News
Enseval Settles US$ 30.7 Million Debt
Bisnis Indonesia, page B2, 2006-10-07
PT Enseval Putera Megatrading has settled its US$ 30.7 million debt to syndicated bank under the co-ordination of Royal Bank of Scotland, Singapore. Although the payment was not due until 2010, the company decided to pay in US$ 5 million main installment as the debt restructure were approved until May 2006. In June 2006, the company has paid US$ 12 million and US$ 13.7 million in September 2006. Hence, per 29 September 2006, the company no longer has any debt.
Kalbe, Dankos, and Enseval Merger Approved
Koran Tempo, page A20, 2005-11-30
Shareholders approve of the merger among PT Kalbe Farma Tbk, PT Dankos Laboratories Tbk, and PT Enseval. If all goes well, the merged company’s shares will be effective on January 2 2006 in the stock market. One Dankos note will be convered to 1.34 Kalbe notes. One Enseval note will be converted to 12,998.8 Kalbe notes. For the shareholders who do not approve of the merge, their shares will be accepted by the company, represented by PT Kresna Graha Sekurindo. Every Kalbe share will be worth Rp.850, Dankos Rp.1,140, and Enseval worth Rp.11 million per share. With this merge, Kalbe Farma will issue new 2 million new shares, from 8.12 billion to 10.16 billion shares. Kalbe Farma and Dankos shares owned by the public (less than 5 percent) decreased from 59.1 percent to 36.87 percent. The assets from the three companies before the merge will also drop from Rp. 9.54 trillion to Rp.4.8 trillion. Kalbe Farma predicts a growth increase of 15 percent. Sales and profit are hoped to increase 18 percent. The post-merger capitalization is hoped to exceed US$1 billion from its current position of US$700 million.
 
Enseval Putera Megatrading Tbk., PT
Indonesia Company Report
Last Update 6-February-2019
Major Businessline : Pharmaceutical, Medical instrument

PT. Dataindo Inti Swakarsa
3rd Floor, Gapura Raya Building
Jl. Bangka Raya No. 4, Pela Mampang Email : info@disb2b.com
Jakarta 12720, Indonesia
Selective Member’s Information US $ Select All
Address 0.66
Telephone number(s) [1] [28-Mar-18] 0.22
Facsimile number(s) [1] [28-Mar-18] 0.44
Email [28-Mar-18] 0.50
Website [28-Mar-18] 0.28
Personnel (Commissioner [5], Director [3]) 4.40
Establishment Date 0.77
Tax Number (NPWP) [28-Mar-18] 0.77
Business Activity [28-Mar-18] 0.44
Legality (Ownership Type) 0.39
Number of employees 0.77
Brands / Trade Mark 0.77
Authorised Capital [28-Mar-18] 3.85
Paid Up Capital [28-Mar-18] 3.85
Auditor(s) [1] [26-Aug-09] 1.32
Shareholder(s) [2] 6.60
Number Of Shares 3.30
Share Nominal Value 3.30
Additional Information [26-Aug-09] 0.88
Profit and Loss [2011,2012,2013,2014,2015]
(Net Sales, Cost of Goods Sold, Gross Profit, Operating Expense, Operating Profit (Loss), Other Income (Expense), Profit (Loss) After Tax, Growth)
Balance Sheet [2011,2012,2013,2014,2015]
(Total Assets, Current Assets, Non Current Assets, Other Assets, Total Liabilities, Current Liabilities, Long Term Liabilities, Minority, Shareholder's Equity)
33.00
Listing History
(First Issue, Founder Shares, Bonus Shares, Stock Split, Stock Split, Stock Split)
0.77
Ratios (Times) & Per Share Data [2011,2012,2013,2014,2015]
(PER, PBV, Current Ratio, Debt to Equity, Leverage, Gross Profit Margin, Operating Profit Margin, Net Profit Margin, Inventory Turnover, Total Assets Turnover, ROI, ROE)
0.77
News
The Merger of 3 Pharmaceutical Companies 0.39
TOTAL PRICE (US$)(RP)
Price 100.001.250.000
Payment Method
Credit Card
Bank Transfer in US$
Bank Transfer in RP
Buy Now

 
Selective Member`s Discount Price
US$
To become a Selective Member
Register
Report Content
PROFIT AND LOSS 2005 2006 2007
Revenue 13,613,840 13,229,085 15,397,484
Cost of Goods N/A N/A N/A
Gross Profit 13,613,840 13,229,085 15,397,484
Net Profit Before Tax 3,139,711 4,528,733 5,123,618
The data above is sample data only
Balance Sheet (In RP Millions) 2005 2006 2007
Total Assets 133,260,087 149,168,842 150,180,752
Non Current Assets 1,888,511 1,935,151 2,024,748
Other Assets 2,885,953 4,075,426 50,103,265
Cash on Hand in Bank 47,751,808 43,551,174 27,213,874
Placement in other Bank 3,697,885 2,558,909 7,344,934
Notes & Securities 48,516,569 57,691,639 10,714,256
Loans 28,329,341 39,280,369 52,778,750
Total Liabilities 120,634,642 135,243,441 134,333,598
Cash
Minority 776 990 1,268
Total Deposits 118,251,011 131,985,222 129,555,406
Call Money 796,988 672,224 720,321
Notes Issued 252,202 425,039 652,439
Borrowings 219,652 484,127 525,316
Other Liabilities 1,114,013 1,675,839 2,878,848
Shareholder"s Equity 12,625,445 13,925,401 15,847,154
The data above is sample data only